Latest data from September 24, 2021
Number of Health Center respondents = 33 (85% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 8,313 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 35.69% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 1,099 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 28.39% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 57.43% | 64.97% |
| White, Hispanic/Latino Patients | 6.06% | 5.10% |
| Black/African American, Non-Hispanic/Latino Patients | 16.87% | 13.38% |
| Black/African American, Hispanic/Latino Patients | 0.57% | 0.73% |
| Asian Patients3 | 0.81% | 0.55% |
| American Indian/Alaska Native Patients3 | 0.45% | 0.45% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.10% | 0.00% |
| Patients with More than one race3 | 3.13% | 2.46% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.90% | 3.09% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 2.24% | 1.73% |
| Unreported/Refused to Report Race and Ethnicity | 8.47% | 7.55% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 1,638 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 63.42% |
| COVID-19 Immunization Series Completed | 2,096 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 61.93% |
| COVID-19 Immunization Series Additional | 152 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 8.66% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 32.60% | 32.73% | 76.32% |
| White, Hispanic/Latino Patients | 14.59% | 13.79% | 0.66% |
| Black/African American, Non-Hispanic/Latino Patients | 21.18% | 18.42% | 5.92% |
| Black/African American, Hispanic/Latino Patients | 0.85% | 1.19% | 0.00% |
| Asian Patients3 | 0.73% | 0.91% | 0.00% |
| American Indian/Alaska Native Patients3 | 0.98% | 0.62% | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.37% | 0.05% | 0.00% |
| Patients with More than one race3 | 3.42% | 3.53% | 0.66% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 14.41% | 14.74% | 0.00% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.71% | 1.91% | 3.95% |
| Unreported/Refused to Report Race and Ethnicity | 9.16% | 12.12% | 12.50% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 12.12% |
| 1 to 24 Hours | 24.24% |
| More Than 24 Hours | 63.64% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 0.00% |
| Staffing to administer the vaccine | 21.21% |
| Vaccine confidence | 60.61% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 6.06% |
| None | 33.33% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 91.52% |
| Average Percent of Health Center Visits Conducted Virtually | 17.12% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 39.39% |
| Number of Mobile Van Sites | 14 |
| Number of Pop-up Clinics | 41 |
| Number of School-Based Vaccination Sites | 6 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 69.70% |
| None | 30.30% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 18.18% |
| Patient awareness/education | 6.06% |
| Staffing capacity | 9.09% |
| Therapy administration/onsite logistics | 12.12% |
| Other | 3.03% |
| None | 69.70% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
